These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 12629824)
1. The ESRD regulatory landscape: a primer & resource. Part 2. Robers S Nephrol News Issues; 2003 Jan; 17(2):22-5. PubMed ID: 12629824 [No Abstract] [Full Text] [Related]
2. Palliative care in patients with CKD. Szromba C Nephrol Nurs J; 2007; 34(5):551-2. PubMed ID: 18041458 [No Abstract] [Full Text] [Related]
3. The social contract and the treatment of permanent kidney failure. Rettig RA JAMA; 1996 Apr; 275(14):1123-6. PubMed ID: 8601933 [No Abstract] [Full Text] [Related]
4. The ESRD regulatory landscape: a primer and resource. Part 1. Robers S Nephrol News Issues; 2002 Dec; 16(13):29-33, 53. PubMed ID: 12596328 [No Abstract] [Full Text] [Related]
5. Lessons from geographic variations in predialysis nephrology care. Winkelmayer WC J Am Soc Nephrol; 2009 May; 20(5):930-2. PubMed ID: 19389840 [No Abstract] [Full Text] [Related]
6. F.D.A. dismisses medical benefit from marijuana. Harris G N Y Times Web; 2006 Apr; ():A1, A23. PubMed ID: 16649276 [No Abstract] [Full Text] [Related]
7. The monthly capitated payment/Part II. Establishing relative work values, looking at practice expenses. Paganini EP Nephrol News Issues; 1996 Apr; 10(4):22-3, 38. PubMed ID: 8716017 [No Abstract] [Full Text] [Related]
8. The coming fiscal crisis: nephrology in the line of fire. Andersen MJ; Friedman AN Clin J Am Soc Nephrol; 2013 Jul; 8(7):1252-7. PubMed ID: 23704301 [TBL] [Abstract][Full Text] [Related]
9. End-stage renal disease therapy: an American success story. Friedman EA JAMA; 1996 Apr; 275(14):1118-22. PubMed ID: 8601932 [No Abstract] [Full Text] [Related]
10. Getting at the heart of quality and economics. Neumann ME Nephrol News Issues; 2007 Mar; 21(4):42. PubMed ID: 17393927 [No Abstract] [Full Text] [Related]
11. Both Urgency and Balance Needed in Addressing Opioid Epidemic: A Report From the National Academies of Sciences, Engineering, and Medicine. Bonnie RJ; Kesselheim AS; Clark DJ JAMA; 2017 Aug; 318(5):423-424. PubMed ID: 28715551 [No Abstract] [Full Text] [Related]
12. The patient-centered medical home and nephrology. DuBose TD; Behrens MT; Berns A; Davis C; Goldfarb S; Hostetter T; Klotman P; Linas S; Owens S; Szczech L; Himmelfarb J J Am Soc Nephrol; 2009 Apr; 20(4):681-2. PubMed ID: 19297553 [No Abstract] [Full Text] [Related]
13. Understanding Washington: a nephrologist's perspective from inside the Beltway. Rubin RJ Am J Kidney Dis; 2013 Dec; 62(6):1042-5. PubMed ID: 24051080 [TBL] [Abstract][Full Text] [Related]
14. From fee-for-service to capitation: factors driving ESRD reimbursement system change. Day LM Nephrol News Issues; 1997 Apr; 11(4):22-3, 31. PubMed ID: 9287685 [No Abstract] [Full Text] [Related]
15. Medicare cuts: hopefully gone, but more likely, not forgotten (by Washington). Rubin R Nephrol News Issues; 1991 Apr; 5(4):16-7. PubMed ID: 1961278 [No Abstract] [Full Text] [Related]
16. Medicare HMOs reveal unique contracting strategies for new ESRD risk demonstration. Public Sect Contract Rep; 1997 May; 3(5):74-6. PubMed ID: 10174874 [No Abstract] [Full Text] [Related]
17. The economic cost of ESRD and Medicare spending for alternative modalities of treatment. United States Renal Data System. Am J Kidney Dis; 1998 Aug; 32(2 Suppl 1):S118-31. PubMed ID: 9713414 [No Abstract] [Full Text] [Related]
18. Capitation in nephrology: the time has come. Bosch JP; Luckenbill L Adv Ren Replace Ther; 1997 Oct; 4(4):325-31. PubMed ID: 9356684 [TBL] [Abstract][Full Text] [Related]
19. Why we need a health-related quality of life CPM. Stec P; Schatell D; Witten B Nephrol News Issues; 2008 Mar; 22(3):28-30, 35. PubMed ID: 18372678 [No Abstract] [Full Text] [Related]
20. IOM study released; calls for up to $640 million more for ESRD, transplant patients. Nephrol News Issues; 1991 May; 5(5):11, 14-6. PubMed ID: 1961285 [No Abstract] [Full Text] [Related] [Next] [New Search]